Joint IOGP-IPIECA position on COVID-19 vaccines

Position paper

This document aims to help companies understand vaccine efficacy and provides guidance for company policy development aimed at achieving high rates of vaccination amongst staff.

IOGP Members can also access all publications via the library in the Members Area

SKU: STA001_211115 Category: Tags: ,


The IOGP-IPIECA joint Health Committee has followed the development, rollout, and real-world efficacy of COVID-19 vaccines since they became available in late 2020. In late 2021, we are confident that vaccines provide one of the most effective tools to mitigate the spread and consequences of COVID-19.

Updated in November 2021

Additional information

Document type

Position Statement